Incidence and survival patterns of clear cell renal cell carcinoma from 2000 to 2017: A SEER Database Analysis

被引:0
|
作者
Zou, Sijue [2 ]
Cui, Liwen [1 ]
Pai, Pearl [1 ]
Lu, Yiping [1 ]
Li, Xiangyang [1 ]
Wang, Gang [1 ]
Huang, Wen [1 ]
Wang, Dan [3 ]
Shaikh, Nikhat [4 ,5 ]
Peng, Zhangzhe [2 ]
Peng, Zhuoming [6 ]
He, Haiyan [1 ]
Liao, Zhouning [1 ]
机构
[1] Univ Hong Kong, Shenzhen Hosp, Dept Nephrol, Shenzhen, Peoples R China
[2] Cent South Univ, Xiangya Hosp, Dept Nephrol, Changsha, Peoples R China
[3] Cent South Univ, Xiangya Hosp, Dept Gen Surg, Changsha, Peoples R China
[4] Univ Med Ctr Hamburg Eppendorf, Dept Med, Hamburg, Germany
[5] Univ Med Ctr Hamburg Eppendorf, Hamburg Ctr Translat Immunol, Hamburg, Germany
[6] Huazhong Univ Sci & Technol, Union Shenzhen Hosp, Dept Resp & Intens Care Med, Shenzhen 518000, Guangdong, Peoples R China
来源
JOURNAL OF CANCER | 2025年 / 16卷 / 05期
关键词
SEER; Clear cell renal cell carcinoma; Incidence; Age mortality;
D O I
10.7150/jca.105713
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Clear cell renal cell carcinoma (ccRCC) incidence and death have considerably changed in recent years. Our study aimed to investigate the incidence, survival, and tumor characteristics of ccRCC in the year of diagnosis. Methods: Our study participants were selected from the SEER database (2000-2017). Age-standardized incidence rates were calculated to compare incidence rates across time. In addition, we used Kaplan-Meier curves to calculate overall survival (OS) and Cox proportional hazards models to explore risk factors associated with mortality outcomes in patients with ccRCC. Results: In the SEER analysis from 2000 to 2017, the increasing trend in age-adjusted incidence of ccRCC has remained relatively stable over the years, increasing from 2.63 per 100,000 in 2000 to 8.79 per 100,000 in 2017. The increase in the incidence of patients at a localized stage plays a decisive role in the overall increase in the incidence of ccRCC. Conclusions: In the general population, patients diagnosed between 2009-2017 had a higher survival rate than those diagnosed between 2000-2008, which is consistent with all stages of the tumor. The incidence of ccRCC increases steadily with the year of diagnosis, while overall survival has significantly improved.
引用
收藏
页码:1591 / 1597
页数:7
相关论文
共 50 条
  • [41] Does immunoscore have a significant effect on survival for non-clear cell renal cell carcinoma as well as clear cell renal cell carcinoma?
    Selvi, Ismail
    Demirci, Umut
    Bozdogan, Nazan
    Basar, Halil
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2021, 53 (06) : 1135 - 1138
  • [42] Analysis of various potential prognostic markers and survival data in clear cell renal cell carcinoma
    Ebru, Tastekin
    Fulya, Oz Puyan
    Hakan, Akdere
    Vuslat, Yurut-Caloglu
    Necdet, Sut
    Nuray, Can
    Filiz, Ozyilmaz
    INTERNATIONAL BRAZ J UROL, 2017, 43 (03): : 440 - 454
  • [43] Integrative radiogenomics analysis for predicting molecular features and survival in clear cell renal cell carcinoma
    Zeng, Hao
    Chen, Linyan
    Wang, Manni
    Luo, Yuling
    Huang, Yeqian
    Ma, Xuelei
    AGING-US, 2021, 13 (07): : 9960 - 9975
  • [44] Clinical characteristics with patterns of relapse and survival analysis of ovarian clear cell carcinoma
    Kaur, S.
    Kerkar, R. A.
    Maheshwari, A.
    Shylasree, T. S.
    Gupta, S.
    Deodhar, K.
    INDIAN JOURNAL OF CANCER, 2016, 53 (02) : 288 - 291
  • [45] Prognostic nomogram for predicting the overall survival rate of patients with uterine clear-cell carcinoma: Based on SEER database
    Huang, Ting
    Lu, Fan
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2024, 166 (02) : 707 - 717
  • [46] Development and validation of a prognostic nomogram for predicting cancer-specific survival in patients with metastatic clear cell renal carcinoma: A study based on SEER database
    Huang, Guangyi
    Liao, Jie
    Cai, Songwang
    Chen, Zheng
    Qin, Xiaoping
    Ba, Longhong
    Rao, Jingmin
    Zhong, Weimin
    Lin, Ying
    Liang, Yuying
    Wei, Liwei
    Li, Jinhua
    Deng, Kaifeng
    Li, Xiangyue
    Guo, Zexiong
    Wang, Liang
    Zhuo, Yumin
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [47] Treatment and Survival Differences in Patients with Large Cell Neuroendocrine Carcinoma of the Lung: A SEER Database Analysis
    Chen, J.
    Chu, X.
    Su, J.
    Chen, B.
    Song, H.
    Huang, Y.
    Zhong, W.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S179 - S180
  • [48] RENAL CELL CARCINOMA AND BRAIN METASTASIS: A SEER ANALYSIS
    Daugherty, Michael
    Daugherty, Emily
    Jacob, Joseph
    Shapiro, Oleg
    Bratslavsky, Gennady
    JOURNAL OF UROLOGY, 2018, 199 (04): : E489 - E489
  • [49] Clinicopathologic features and survival outcomes of signet cell carcinoma of the appendix: Analysis of the SEER database.
    Abushalha, Kamelah
    Tuqan, Wa'el
    Albagoush, Sara
    Abulaimoun, Sawsan
    Silberstein, Peter T.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [50] Morphologic Patterns in Primary Tumor Determines Overall Survival in a Cohort of Patients with Clear Cell Renal Cell Carcinoma
    Sirohi, Deepika
    Chipman, Jonathan
    Knudsen, Beatrice
    Raps, Evan
    Barry, Marc
    Albertson, Daniel
    Mahlow, Jonathon
    Liu, Ting
    Sharma, Prayushi
    Hahn, Andrew
    Agarwal, Neeraj
    LABORATORY INVESTIGATION, 2021, 101 (SUPPL 1) : 613 - 614